Pooled analysis of five-year survival: neoadjuvant immunotherapy for melanoma translates to real-world care
An international pooled study led by Professor Georgina Long AO, and published in Nature Medicine, showed patients whose tumours responded well to neoadjuvant immunotherapy had outstanding 5-year survival.